ECDC Expert meeting on non-pharmaceutical countermeasures for Pandemic flu
The meeting focused on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
Joint meeting EU/EEA Tuberculosis (TB) Surveillance Network and WHO/Europe National TB Programme Managers
This meeting brought together TB experts from countries belonging to the WHO European Region and surveillance experts from EU/EEA countries to discuss the common goals of eliminating TB in Europe.
World Tuberculosis Day - 24 March 2016
Marked each year on 24 March, World Tuberculosis Day gives the occasion to raise awareness about tuberculosis (TB) and to advocate more efforts to eliminate it. ECDC has launched the latest surveillance data and materials on interventions addressing vulnerable groups.
World Tuberculosis Day - 2016
Tuberculosis is a persistent public health threat but it could be eliminated if specific action is taken. In Europe, most countries have low TB rates. The disease tends to concentrates among the marginalised, the poorest and most vulnerable groups.
Meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis and Wolfheze Workshops
The 2015 meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis was held in The Hague, the Netherlands, on 26-27 May 2015. The meeting was organised jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe for TB surveillance experts from WHO European region including European Union/European Economic Area (EU/EEA) Member States (MSs). The participants included 47 nominated contact points for TB surveillance from 42 countries, as well as experts from ECDC and WHO/Europe, WHO headquarters and country offices. In addition, experts from seven EU Enlargement Countries and from the KNCV TB Foundation (the Netherlands) attended the meeting as observers.